![Günter Kahler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Günter Kahler
Comptroller/Controller/Auditor en Licensing Executives Society (Austria) .
Perfil
Günter Kahler is currently a Member-Management Board & Controller at Licensing Executives Society (Austria) since 2012.
He is also a Member-Management Board at St. Joseph Privatstiftung since 2012.
Previously, he served as Co-Chairman-Supervisory Board at SANOCHEMIA Pharmazeutika GmbH in 2010.
Mr. Kahler completed his undergraduate and graduate degrees at Vienna University of Economics & Business in 1962.
Cargos activos de Günter Kahler
Empresas | Cargo | Inicio |
---|---|---|
Licensing Executives Society (Austria) | Comptroller/Controller/Auditor | 28/09/2012 |
St. Joseph Privatstiftung | Corporate Officer/Principal | 28/09/2012 |
Antiguos cargos conocidos de Günter Kahler.
Empresas | Cargo | Fin |
---|---|---|
SANOCHEMIA PHARMAZEUTIKA AG | Presidente | - |
Formación de Günter Kahler.
Vienna University of Economics & Business | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
SANOCHEMIA Pharmazeutika GmbH
![]() SANOCHEMIA Pharmazeutika GmbH Pharmaceuticals: MajorHealth Technology SANOCHEMIA Pharmazeutika GMBH engages in the manufacture and distribution of pharmaceutical products. It operates through the following segments: Production, Human Pharmaceuticals, Veterinary Pharmaceuticals, Research and Development, and Others. The Production segment focuses on the synthesis of active pharmaceutical substances, drug formulation and pharmaceutical production. The Human Pharmaceuticals segment comprises of diagnostic activities including products such as X-ray and magnetic resonance imaging agents. The Veterinary Pharmaceuticals segment involves in veterinary medicine production, administration, and drug development. The Research and Development segment implements clinical trials and acquires licenses for the drugs. The company was founded by Werner Josef Frantsits on November 13, 1990 and is headquartered in Vienna, Austria. | Health Technology |
Licensing Executives Society (Austria) | |
St. Joseph Privatstiftung |
- Bolsa de valores
- Insiders
- Günter Kahler